MedPath

A prospective study on comprehensive sampling to search exacerbation factors and efficacy predictors in patients with autoimmune and immune related disease

Not Applicable
Recruiting
Conditions
Patients with autoimmune/immune-related diseases such as ulcerative colitis, Crohn&#39
s disease, Bechet disease, immune-check point inhibitor related colitis
Registration Number
JPRN-UMIN000041268
Lead Sponsor
Sapporo Medical University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who have not confirmed the diagnosis 2. Patients who do not get written consent 3. Patients who the doctor judges as inappropriate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expression of inflammatory cytokines in the intestinal tract, analysis of intestinal bacterial flora, measurement of fecal metabolites, identification of disease susceptibility genes
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath